contact us
On Wednesday, Melinta Therapeutics said its approved antibiotic Baxdela had been granted priority review for use in community-acquired bacterial pneumonia (CAPB). The FDA is expected to make its decision by October 24.
Do Not Allow Advertisers to Use My Personal information